- Home
- BIRD vs MODD Comparison
BIRD vs MODD Comparison
Compare BIRD & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIRD | MODD |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 33.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BIRD | MODD |
|---|---|---|
| Price | $4.56 | $0.35 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | 73.6K | ★ 487.1K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $160,639,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.93 | $0.28 |
| 52 Week High | $12.85 | $1.68 |
Technical Indicators
Market Signals| Indicator | BIRD | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 32.94 | 34.88 |
| Support Level | $4.76 | $0.30 |
| Resistance Level | $5.40 | $0.47 |
| Average True Range (ATR) | 0.31 | 0.05 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 5.62 | 35.06 |
Price Performance
Historical ComparisonAbout BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.